STEROID CONJUGATES AS POTENTIAL ANTI-CANCER AGENTS-Reference-Cited by-同舟云学术

STEROID CONJUGATES AS POTENTIAL ANTI-CANCER AGENTS

Published:2020-03-22 Issue:1 Volume:19 Page:22-52
ISSN:1726-9792
Container-title:Russian Journal of Biotherapy
language:
Short-container-title:Rossijskij bioterapevtičeskij žurnal

Author:

Zolottsev V. A.¹^ORCID,Latysheva A. S.¹^ORCID,Pokrovsky V. S.²^ORCID,Khan I. I.³,Almanza R. L. M.³,Misharin A. Y.¹

Affiliation:

1. Institute of Biomedical Chemistry

2. Institute of Biomedical Chemistry; N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Peoples’ Friendship University of Russia (RUDN University)

3. Peoples’ Friendship University of Russia (RUDN University)

Abstract

The review is dedicated to results of investigations of steroid conjugates published predominantly over the past decade. It consists of three parts in which the data concerning biological activity of steroid conjugates with known drugs, steroid dimers, and steroid conjugates with some natural compounds, their fragments and related derivatives and analogs, are discussed. The structures of 231 steroid conjugates and their anti-cancer properties are presented.

Publisher

Publishing House ABV Press

Reference116 articles.

1. Hadden M.K., Blagg B.S.J. Dimeric approaches to anti-cancer chemotherapeutics. Anticancer Agents Med Chem 2008;8(7):807–16. DOI: 10.2174/187152008785914743.

2. Prokopiou E.M., Ryder S.A., Walsh J.J. Tumour vasculature targeting agents in hybrid/conjugate drugs. Angiogenesis 2013;16(3):503–24. DOI: 10.1007/s10456-013-9347-8.

3. Bailly C. Cell-targeted cytotoxics: a new generation of cytotoxic agents for cancer treatment. Phytochemistry Rev 2014;13(1):171–81. DOI: 10.1007/s11101-013-9300-x.

4. Rana A., Alex J.M., Chauhan M. et al. А review on pharmacophoric designs of antiproliferative agents. Med Chem Res 2015;24(3):903–20. DOI: 10.1007/s00044-014-1196-5.

5. Nepali K., Sharma S., Sharma M. et al. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur J Med Chem 2014;77:422–87. DOI: 10.1016/j.ejmech.2014.03.018.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiproliferative activity of the novel CYP17A1 inhibitor alsevirone;Russian Journal of Oncology;2023-12-20

2. A Comprehensive Review on Steroidal Bioconjugates as Promising Leads in Drug Discovery;ACS Bio & Med Chem Au;2022-03-23